James Miser, M.D.
- Pediatric Hematology-Oncology
Other Languages Spoken
I am passionate about caring for children with cancer and helping them through their challenges. - James Miser, M.D.
For over 40 years, in places near and far, James Miser, M.D., a gifted pediatric oncologist and hematologist has championed the health and well-being of children, especially those with special challenges.
Joining City of Hope in 1995, Dr. Miser was the architect of our pediatric oncology division. He also served as chief executive officer and chief medical officer of City of Hope National Medical Center, and oversaw the development of our City of Hope Helford Clinical Research Hospital.
Dr. Miser has also extended his expertise and commitment to numerous institutions in Southern California, as well as the National Cancer Institute and Mayo Clinic, and internationally at facilities in Taiwan and Thailand.
His love for young people begins at home. Dr. Miser is the proud father of 10 adopted children, eight with disabilities.
- 2019–present, Clinical Professor, Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
- 2014–2016, Chief Medical Information Officer, Bumrungrad International Hospital, Bangkok, Thailand
- 2013–2015, Provisional Medical Staff, Antelope Valley Hospital, Lancaster, California
- 2012–2019, Provisional Medical Staff, White Memorial Medical Center, Los Angeles, California
- 2012–present, Chair Professor, College of Medical Sciences & Technology, Taipei Medical University, Taipei, Taiwan
- 2009–2019, Professor of Pediatrics and Active Staff, City of Hope National Medical Center, Duarte, California
- 2004–2006, Acting Chair of Pediatrics, Acting Chief Operating Officer and Chief Medical Officer, City of Hope National Medical Center, Duarte, California
- 2001–2006, President and Chief Executive Officer, City of Hope National Medical Center, Duarte, California
- 2000–2008, Active Staff, White Memorial Medical Center, Los Angeles, California
- 1998–2007, Active Staff, UCI Medical Center, Orange, California
- 1998–2004, Affiliate Staff, Children’s Hospital of Orange County, Orange, California
- 1997–2003, Associate Consulting Staff Member, Orthopaedic Hospital, Los Angeles, California
- 1997–1999, Provisional Member, Cedars Sinai Medical Center, Los Angeles, California
- 1996–2001, Medical Director, Ambulatory Care Services, City of Hope National Medical Center, Duarte, California
- 1995–2007, Active Staff, City of Hope National Medical Center, Duarte, California
- 1995–2006, Professor, Division of Pediatrics, City of Hope National Medical Center, Duarte, California
- 1995–2002, Director, Division of Pediatrics, Chair, Department of Pediatric Hematology/Oncology, City of Hope National Medical Center, Duarte, California
- 1995, John R. Hartmann Endowed Professor of Pediatrics, University of Washington, Seattle, Washington
- 1991–1995, John R. Hartmann Endowed Associate Professor of Pediatrics, University of Washington, Seattle, Washington
- 1991–1995, Clinical Director, Division of Hematology/Oncology, Department of Pediatrics, Children’s Hospital and Medical Center, Seattle, Washington
- 1989–1991, Associate Professor of Pediatrics, Mayo School of Medicine, Consultant, Pediatric Hematology-Oncology, Mayo Clinic, Rochester, Minnesota
- 1986–1989, Associate Professor of Pediatrics, Mayo School of Medicine, Senior Associate Consultant, Mayo Clinic, Rochester, Minnesota
- 1982–1986, Cancer Expert, Pediatric Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, National Institute of Health, Bethesda, Maryland
- 1978–1982, Assistant Professor, Division of Hematology-Oncology, Department of Pediatrics of the Ohio State University, Columbus, Ohio
- 1973, M.D. University of Washington, Seattle, Washington
- 1971, B.M.S. Dartmouth Medical School, Hanover, New Hampshire
- 1969, B.A. Dartmouth College, Hanover, New Hampshire
- 1975–1977, Fellow, Pediatric Hematology-Oncology Children's Hospital and Medical Center, and the University of Washington, Seattle, Washington
- 1974–1975, Resident, Children's Hospital and Medical Center and the University of Washington, Seattle, Washington
- 1973-1974, Intern, Children's Hospital and Medical Center and the University of Washington, Seattle, Washington
- 1980, Diplomat, American Board of Pediatrics, Sub-Board of Pediatric Hematology-Oncology
- 1979, Diplomat, American Board of Pediatrics
Seibel NL1,2, Chi YY3, Perlman EJ4, Tian J3, Sun J5, Anderson JR6, Ritchey ML7, Thomas PR8, Miser J9, Kalapurakal JA10, Grundy PE11, and Green DM12. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5). Pediatr Blood Cancer. 2019 Jan;66(1):e27450. doi: 10.1002/pbc.27450. Epub 2018 Sep 25.
Tsai ML1, Chen CL2, Hsieh KL3, Miser JS4, Chang H1, Liu YL5, and Wong TT6. Seizure characteristics are related to tumor pathology in children with brain tumors. Epilepsy Res. 2018 Nov ;147 :15-21. doi:10.1016 / j.eplepsyres.2018.08.007. Epub 2018 Aug 23.
Huang PW, Liu YL, Miser JS, Lee CH, Kao CY, and Chen SH. Carcinoid tumor arising from a retroperitoneal mature cystic teratoma. Pediatr Neonatol. 2017 Nov 23. pii: S1875-9572(17)30035-9. doi: 10.1016/j.pedneo.2017.11.016. [Epub ahead of print] PubMed PMID: 29295805.
Chen SH, Kuo YT, Liu YL, Chen BJ, Lu YC, and Miser JS. Acute Myeloid Leukemia Presenting with Sweet Syndrome: A Case Report and Review of the Literature. Pediatr Neonatol. 2017 Jun;58(3):283-284. doi: 10.1016/j.pedneo.2016.05.002. Pub 2016 Aug 5. PubMed PMID: 27720691.
Liu YL, Lu MY, Chang HH, Lu CC, Lin DT, Jou ST, Yang YL, Huang SF, Jeng YM, Lee H, Miser JS, Lin KH, Liao YF, Hsu WM, and Tzen KY. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma. Oncotarger. 2016 Mar 5. Doi: 10.18632/oncotarget.7933
Chen CI, Kao PF, Wu, MY, Fang YA, Miser JS, Liu JC, and Sung LC. Influenza Vaccine is Associated with Lower Risk of Acute Coronary Syndrome in Elderly Patients with Chronic Kidney Disease. Medicine (Baltimore). 2016 Feb;;95(5):e2588.doi 10.1097/MD.0000000000002588.
Chen SH, Fan CK, Miser JS, Liu YL, Huang YJ, and Wang CY. An infant boy with widespread ecchymoses and severe eosinophilia. J Microbiol Immunol Infect. 2015 Apr;48(2):233-5. doi:10.1016/j.jmii.2014.07.003. Epub 2014 Oct 8.
Chen CI, Kuan CF, Miser JS, Fang YA, Lam C, Chiu WT, and Li YC. Comorbidity as an independent risk factor in patients with cancer: an 8-year population-based study. Asia Pac J Public Health. 2015 Mar;27(2):NP590-9. doi:10.1177/1010539513481491. Epub 2013 Mar 27.
Chen CI, Kuan CF, Fang YA, Liu SH, Liu JC, Wu LL, Chang CJ, Yang HC, Hwang J, Miser JS, and Wu SY. Cancer risk in HBV patients with statin and metformin use: a population-based cohort study. Medicine (Baltimore). 2015 Feb;94(6):e462. doi: 10.1097/MD.0000000000000462.
Liu YL, Lo WC, Chiang CJ, Yang YW, Lu MY, Hsu WM, Ho WL, Li MJ, Miser JS, Lin DT, and Lai MS. Incidence of cancer in children aged 0-14 years in Taiwan, 1996-2010. Cancer Epidemiol. 2015 Feb;39(1):21-8. doi:10.1016/j.canep.2014.11.010. Epub 2015 Jan 16.
Liu YL, Miser JS, and Hsu WM. Risk-directed therapy and research in neuroblastoma. J Formos Med Assoc. 2014 Dec;113(12):887-9. doi:10.1016/j.jfma.2014.11.001. Epub 2014 Dec 9.Sung LC, Chen CI, Fang YA, Lai CH, Hsu YP, Cheng TH, Miser JS, and Liu JC. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study. Vaccine. 2014 Jun 24;32(30):3843-9. doi:10.1016/j.vaccine.2014.04.064. Epub 2014 May 14.Lam C, Kuan CF, Miser JS, Hsieh KY, Fang YA, Li YC, Hsu CW, Chen RJ, and Chen CI. Emergency department utilization can indicate early diagnosis of digestive tract cancers: A population-based study in Taiwan. Comput Methods Programs Biomed. 2014 Jul;115(3):103-9. doi:10.1016/j.cmpb.2014.04.002. Epub 2014 Apr 29.Chen CI, Miser JS, Kuan CF, Fang YA, Lam C, and Li YC. Critical laboratory result reporting system in cancer patients. Comput Methods Programs Biomed. 2013 Jul;111(1):249-54. doi:10.1016/j.cmpb.2013.03.008. Epub 2013 Apr 7.Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J, Shamberger RC, Goorin A, Miser JS, Meyer J, Arndt CA, Sailer S, Marcus K, Perlman E, Dickman P, and Grier HE: Dose-intensified Compared with Standard Chemotherapy for Nonmetastatic Ewing sarcoma family of tumors: A Children’s Oncology Group Study. J Clin Oncol 27(15):2536-41, Epub Apr 2009.
- 2009–Present, Member, American Academy of Pediatrics
- 2006–2007, Member, American College of Healthcare Executives
- 1997–2006, Member, American Medical Association
- 1990–2006, Associate Editor, American Journal of Clinical Oncology
- 1988–2006, Member, Extramural Editorial Board, Physicians Data Query, National Cancer Institute Information System, National Institutes of Health
- 2006, Spirit of Life Award, City of Hope, Duarte, California
- 2002–2003, America’s Top Pediatricians Award, Awarded by the Consumer’s Research Council of America
- 1991–1992, Outstanding Teacher Award, Awarded by Children's Hospital and Medical Center (Seattle, Washington) House Staff
- 1987–1988, Outstanding Teacher Award, Awarded by the Mayo Clinic (Rochester, Minnesota) Pediatric House Staff
- 1979–1980, Outstanding Attending Physician, Awarded by Columbus Children's Hospital (Columbus, Ohio) House Staff